Drug Type Monoclonal antibody |
Synonyms izeltabart |
Target |
Mechanism ADAM9 inhibitors(ADAM metallopeptidase domain 9 inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |